Drug Profile
Amikacin/fosfomycin inhalation system - Savara Pharmaceuticals
Alternative Names: AFIS; Amikacin/fosfomycin eFlow® Nebulizer system; eFlow Inline SystemLatest Information Update: 15 May 2019
Price :
$50
*
At a glance
- Originator Cardeas Pharma
- Class Aminoglycosides; Antibacterials; Epoxy compounds; Organophosphorus compounds; Phosphonic acids; Phosphoric acid esters; Small molecules
- Mechanism of Action Cell wall inhibitors; Protein 30S ribosomal subunit inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II Ventilator associated pneumonia
- No development reported Bronchitis